The briefing
A study reports that pegcetacoplan sustains reductions in proteinuria across diverse immune complex membranoproliferative glomerulonephritis populations. Efficacy appeared consistent regardless of immunosuppressant use, baseline proteinuria, or age.
Original headline
Pegcetacoplan Sustains Proteinuria Reduction Across Diverse IC-MPGN Populations